156 related articles for article (PubMed ID: 26699264)
21. Biology of childhood acute lymphoblastic leukemia.
Bhojwani D; Yang JJ; Pui CH
Pediatr Clin North Am; 2015 Feb; 62(1):47-60. PubMed ID: 25435111
[TBL] [Abstract][Full Text] [Related]
22. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation.
Sakamoto K; Imamura T; Asai D; Goto-Kawashima S; Yoshida H; Fujiki A; Furutani A; Ishida H; Aoki Y; Hosoi H
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e136-9. PubMed ID: 24072241
[TBL] [Abstract][Full Text] [Related]
23. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
24. [Familial acute lymphoblastic leukemia].
Moriyama T
Rinsho Ketsueki; 2016 Jul; 57(7):900-9. PubMed ID: 27498737
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
26. Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.
Abaji R; Ceppi F; Patel S; Gagné V; Xu CJ; Spinella JF; Colombini A; Parasole R; Buldini B; Basso G; Conter V; Cazzaniga G; Leclerc JM; Laverdière C; Sinnett D; Krajinovic M
Pharmacogenomics; 2018 Oct; 19(15):1181-1193. PubMed ID: 30191766
[TBL] [Abstract][Full Text] [Related]
27. Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients.
Shin SY; Lee H; Lee ST; Choi JR; Jung CW; Koo HH; Kim SH
Sci Rep; 2021 Apr; 11(1):8893. PubMed ID: 33903686
[TBL] [Abstract][Full Text] [Related]
28. Adult Acute Lymphoblastic Leukemia: A Genetic Overview and Application to Clinical Practice.
Jacobson S; Tedder M; Eggert J
Clin J Oncol Nurs; 2016 Dec; 20(6):E147-E154. PubMed ID: 27857258
[TBL] [Abstract][Full Text] [Related]
29. Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia.
Pommert L; Burns R; Furumo Q; Pulakanti K; Brandt J; Burke MJ; Rao S
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1335. PubMed ID: 33503336
[TBL] [Abstract][Full Text] [Related]
30. An overview of genetic predisposition to familial hematological malignancies.
Hamadou WS; Bouali N; Besbes S; Mani R; Bardakci F; Siddiqui AJ; Badraoui R; Adnan M; Sobol H; Soua Z
Bull Cancer; 2021; 108(7-8):718-724. PubMed ID: 34052033
[TBL] [Abstract][Full Text] [Related]
31. Familial risks for childhood acute lymphocytic leukaemia in Sweden and Finland: far exceeding the effects of known germline variants.
Kharazmi E; da Silva Filho MI; Pukkala E; Sundquist K; Thomsen H; Hemminki K
Br J Haematol; 2012 Dec; 159(5):585-8. PubMed ID: 23025517
[TBL] [Abstract][Full Text] [Related]
32. Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia.
Winer P; Muskens IS; Walsh KM; Vora A; Moorman AV; Wiemels JL; Roberts I; Roy A; de Smith AJ
Blood Adv; 2020 Feb; 4(4):672-675. PubMed ID: 32084258
[TBL] [Abstract][Full Text] [Related]
33. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia.
Mosor M; Ziółkowska I; Pernak-Schwarz M; Januszkiewicz-Lewandowska D; Nowak J
Leukemia; 2006 Aug; 20(8):1454-6. PubMed ID: 16810201
[No Abstract] [Full Text] [Related]
34. Strengths and weaknesses of gene association studies in childhood acute lymphoblastic leukemia.
Semsei AF; Antal P; Szalai C
Leuk Res; 2010 Mar; 34(3):269-71. PubMed ID: 19716175
[No Abstract] [Full Text] [Related]
35. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
[TBL] [Abstract][Full Text] [Related]
36. Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.
Urayama KY; Chokkalingam AP; Manabe A; Mizutani S
Int J Hematol; 2013 Jan; 97(1):3-19. PubMed ID: 23239135
[TBL] [Abstract][Full Text] [Related]
37. The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.
Pei JS; Hsu CM; Tsai CW; Chang WS; Ji HX; Hsiao CL; Miao CE; Hsu YN; Bau DT
PLoS One; 2015; 10(3):e0119776. PubMed ID: 25793509
[TBL] [Abstract][Full Text] [Related]
38. Array CGH in human leukemia: from somatics to genetics.
van der Veken LT; Buijs A
Cytogenet Genome Res; 2011; 135(3-4):260-70. PubMed ID: 21893961
[TBL] [Abstract][Full Text] [Related]
39. Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572, 2001.
Taylor GM; O'Brien HP; Greaves MF; Ravetto PF; Eden OB
Cancer Res; 2003 Oct; 63(19):6563-4; author reply 6565. PubMed ID: 14559852
[No Abstract] [Full Text] [Related]
40. Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Schütte P; Möricke A; Zimmermann M; Bleckmann K; Reismüller B; Attarbaschi A; Mann G; Bodmer N; Niggli F; Schrappe M; Stanulla M; Kratz CP
Eur J Med Genet; 2016 Mar; 59(3):143-51. PubMed ID: 26732628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
